Mesothelioma Surgery
Surgery plays a role in multimodal treatment of mesothelioma. It can extend survival and improve symptoms. Some minor surgeries can also help diagnose peritoneal and pleural mesothelioma. Surgery-based treatment plans generally result in the most favorable prognoses.
Learn More About Mesothelioma Surgery in Our Free GuideMesothelioma Surgery Options
Mesothelioma surgeries are medical procedures that remove cancer cells from a person’s body. Surgery is a way to treat mesothelioma. But it can also help diagnose cancer, manage symptoms and boost quality of life.
Each patient’s mesothelioma surgery options depend on several factors. These include the patient’s:
- Overall health
- Stage at diagnosis
- Type of mesothelioma
Some patients may be eligible for multimodal treatment, which combines two or more therapies. It is often the most effective way to extend life expectancy for mesothelioma patients. Treatment plans commonly include surgery with radiation, chemotherapy or immunotherapy.
In a recent study, looking at 350 pleurectomies, having heated intrapleural chemotherapy affected survival in a very significant way compared to patients that did not.
Raphael Bueno, MD
Doctors weigh many factors when recommending any mesothelioma treatment, including surgery. One of the most important considerations is the treatment goal. There is currently no cure for malignant mesothelioma. This means procedures generally aim to diagnose cancer, shrink tumors or ease symptoms.
Diagnostic surgery procedures help determine the cause of a patient’s symptoms. Biopsies are a common type of diagnostic surgery for all types of mesothelioma.
Therapeutic surgeries aim to extend survival by removing tumors. Pleurectomy/decortication is a common therapeutic surgery for pleural mesothelioma.
Palliative surgeries help manage symptoms and improve quality of life. Surgeries that drain cancer-related swelling (effusion fluid) are common palliative procedures for most types of mesothelioma.
Surgery for Pleural Mesothelioma
Pleural mesothelioma surgeries range from minor to extensive. In general, symptom-management procedures are less serious. Surgeries intended to extend life are more aggressive operations. Common pleural mesothelioma surgeries include pleurectomy/decortication (P/D) and extrapleural pneumonectomy (EPP).
- Goal: To extend life in combination with other treatments
- Description: A surgery that removes the lining around the lung (the pleura) and leaves both lungs in place
- Goal: To extend life in combination with other treatments
- Description: A risky surgery that removes the pleura and the affected lung
- Goal: To ease symptoms
- Description: A procedure that drains excess fluid from the lining around the lung
- Goal: To ease symptoms
- Description: A procedure that helps prevent fluid buildup around the lung
Who Is Eligible for Pleural Mesothelioma Surgery?
In general, pleural mesothelioma patients who are in good health with stage 3 or lower cancer may qualify for surgery. Factors that can affect eligibility include:
- Ability to engage in everyday activity (also known as performance status)
- Age
- Extent of cancer spread (metastasis)
- Mesothelioma cell type
- Other conditions the patient has (also known as comorbidities)
- Patient preferences
- Stage of cancer at diagnosis
Patients interested in surgery should discuss their options with a mesothelioma surgeon. An experienced specialist can help patients understand the potential risks and benefits.
Surgery for Peritoneal Mesothelioma
Peritoneal mesothelioma surgeries may aim to improve symptoms or extend survival. Options include cytoreductive surgery (CRS) and paracentesis. CRS is also known as debulking or peritonectomy. It is usually followed by HIPEC. HIPEC stands for hyperthermic intraperitoneal chemotherapy. It is a heated chemotherapy wash applied to the abdomen.
- Goal: To extend life in combination with other treatments like HIPEC
- Description: A type of cytoreductive surgery (CRS) that removes the lining of the abdomen (the peritoneum) and other visible tumors
- Goal: To ease symptoms
- Description: A procedure that drains excess fluid from the lining of the abdomen
Patients may also undergo other types of chemotherapy after CRS, including:
- Early postoperative intraperitoneal chemotherapy (EPIC)
- Normothermic intraperitoneal chemotherapy (NIPEC)
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
Who Is Eligible for Peritoneal Mesothelioma Surgery?
Eligibility for peritoneal mesothelioma surgery depends on several factors, including:
- Age
- Cancer cell type
- How far the cancer has spread (also known as metastasis)
- Other conditions the patient has (also known as comorbidities)
- Stage of disease
Doctors consider these factors when assessing a patient’s eligibility. Some patients who are initially ineligible for surgery may become eligible with the right treatments. For example, PIPAC has reduced tumors enough in some ineligible patients that they became eligible for surgery.
Surgeries for Rare Types of Mesothelioma
Pericardial and testicular mesothelioma are both rare types of mesothelioma. As such, surgery options for testicular and pericardial mesothelioma are not well documented. Experienced doctors can determine surgery eligibility based on a patient’s individual case.
This surgery may aim to relieve symptoms or extend survival. It consists of removing all or part of the lining around the heart.
This procedure aims to relieve symptoms of pericardial effusion. It consists of draining excess fluid from the lining around the heart.
Surgery Options for Testicular Mesothelioma
Surgery for testicular mesothelioma is not well documented because it is one of the rarest forms of asbestos cancer. It accounts for less than 1% of all mesothelioma cases. Specific treatment guidelines for testicular mesothelioma have not yet been developed. Doctors may recommend a radical orchiectomy to treat this disease. A radical orchiectomy removes a testicle.
Some evidence shows that surgery for testicular mesothelioma is more effective at extending survival than surgery for other types of mesothelioma.
Who Is Eligible for These Types of Surgery?
There are no official treatment guidelines for pericardial or testicular mesothelioma. An experienced doctor can help determine a patient’s eligibility based on their individual case.
Other Mesothelioma Surgeries
Patients with any type of mesothelioma may undergo minor surgeries to help diagnose their conditions. Types of diagnostic surgeries include:
- Laparoscopy: A doctor makes a small incision in the abdomen and inserts a device called a laparoscope. This device can collect samples and also has a camera component. It is commonly used to diagnose peritoneal mesothelioma.
- Laparotomy: A doctor makes a large incision in the abdomen. This allows the doctor to directly collect samples and view tissue. These samples can be used to diagnose peritoneal mesothelioma.
- Mediastinoscopy: A doctor makes a small incision in the chest and inserts a device called a mediastinoscope. The device is similar to a laparoscope. It may be used to diagnose malignant pleural mesothelioma.
- Thoracoscopy: A doctor makes a small incision in the chest and inserts a device called a thoracoscope. The device is similar to a laparoscope. It is recommended for obtaining an adequate biopsy sample in pleural mesothelioma patients.
- Thoracotomy: A doctor makes a large incision in the chest. The procedure is similar to a laparotomy and may be used to collect samples to diagnose pleural mesothelioma.
Mesothelioma patients may also undergo surgery as a form of palliative care. Any surgery intended to treat symptoms or boost quality of life can be considered palliative.
Questions About Mesothelioma Surgery? Ask experienced mesothelioma advocate Jennifer Lucarelli Ask a QuestionMesothelioma Prognosis After Surgery
Surgery-based combination treatments generally provide the best prognosis for mesothelioma. In studies, patients have lived 5 years and longer with this type of treatment. Life expectancy after surgery depends on patient factors and treatment details. Tumor cell type and location can also affect prognosis.
- Treatment: Chemotherapy, surgery and optional post-surgery chemo
- Key Results
- Median survival: 57 months
- 3-year survival rate: 65%
- Treatment: Surgery and heated chemotherapy (HIPEC)
- Key Results
- Median survival: 67 months
- 3-year survival rate: 62%
The multimodal plans above extended survival further than individual treatments. Patient survival times for solo treatments include:
- Pleural mesothelioma treated with checkpoint inhibitors: 18 months
- Peritoneal mesothelioma treated with chemotherapy drugs: 13 months
Surgery-based multimodal therapies may improve survival for pericardial and testicular mesothelioma patients. Anyone interested in mesothelioma surgery should discuss their options with an expert. Doctors who specialize in this rare cancer can explain the benefits and risks. They may also recommend clinical trials that offer access to experimental treatments.
Mesothelioma Surgery Side Effects
Like all medical procedures, surgeries come with a risk of negative effects. Common mesothelioma surgery side effects include bleeding, pain, respiratory issues and pneumonia. But these problems don’t affect every patient. Mesothelioma surgeons can explain the likelihood of side effects.
- Anesthesia complications
- Bleeding
- Blood clots
- Damage to nearby tissues
- Digestive problems
- Fatigue
- Heart complications
- Infection
- Pain
- Pneumonia
- Respiratory problems
Some factors may increase a person’s chance of experiencing surgery side effects. For example, negative effects may vary if surgery is combined with other treatments, like chemotherapy and radiation. Patients can discuss potential side effects with their oncology teams. After surgery, the mesothelioma cancer center or oncology team can help manage post-surgical conditions.
Learn About Financial Assistance Available for Treatment Costs Learn more with our free information packet Get Help NowWhat Is the Recovery Process for Mesothelioma Surgery?
The mesothelioma surgery recovery process varies depending on the type of surgery. Patients who undergo more aggressive surgeries may spend several weeks in the hospital. These patients often need extra recovery time at home as well. Other, less invasive surgeries may have quicker recovery times. Other factors, like patient health and surgery side effects, may also affect recovery time.
General recovery processes for each type of surgery may be as follows:
- Diagnostic surgery: Recovery from diagnostic procedures is often relatively quick. Biopsies and other diagnostic surgeries are minimally invasive procedures. For example, patients who undergo a laparoscopy usually recover within a week. Doctors may recommend patients avoid strenuous activity and keep the incision site clean.
- Palliative surgery: Palliative surgeries may be less invasive than therapeutic options. Patients may need days or more than a week to recover. For example, patients who undergo pleurodesis, which collapses the pleural space, may spend 5 – 7 days in the hospital to recover. Patients who undergo a paracentesis to drain excess fluid may only need a day to recover.
- Therapeutic surgery: Therapeutic surgeries are often the most invasive and aggressive. Recovery from a serious procedure may take many weeks to months. For example, a patient may need 8 – 10 weeks to recover from an EPP. Recovery may take longer, depending on various factors.
Patients can talk to their doctors to understand what the recovery process may be like for their specific surgeries.
Common Questions About Surgeries for Mesothelioma
Can mesothelioma be removed with surgery?
How long does mesothelioma surgery take?
Can mesothelioma be cured with surgery?
How successful is surgery for mesothelioma?
Which are the most common therapeutic surgeries for pleural mesothelioma?
Note: This page contains statistics gleaned from large groups of patients. These statistics cannot forecast a single patient’s risk, cancer experience or the success of any given treatment. Patients should discuss all cancer screening and treatment decisions with an experienced oncologist.
Sources
Baas P, Scherpereel A, Nowak AK, Fujimoto N, Peters S, Tsao AS, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021 Jan;397(10272):375–86.
Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M. Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (Hipec). Eur J Cancer. 2013 Oct;49(15):3140–8.
Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016 Dec;25(142):472–86.
Bilancia R, Nardini M, Waller DA. Extended pleurectomy decortication: the current role. Transl Lung Cancer Res. 2018 Oct;7(5):556–61.
Bueno R, Opitz I, IASLC Mesothelioma Taskforce. Surgery in malignant pleural mesothelioma. J Thorac Oncol. 2018 Nov;13(11):1638–54.
Chicago Consensus Working Group. The chicago consensus on peritoneal surface malignancies: management of peritoneal mesothelioma. Ann Surg Oncol. 2020 Jun;27(6):1774–9.
Cutting without hope of cure. AMA Journal of Ethics. 2021 Oct 1;23(10):E759-760.
Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the time2 randomized controlled trial. JAMA. 2012 Jun 13;307(22):2383–9.
Domen A, Berzenji L, Hendriks JMH, Yogeswaran SK, Lauwers P, Van Meerbeeck JP, et al. Extrapleural pneumonectomy: still indicated? Transl Lung Cancer Res. 2018 Oct;7(5):550–5.
Enewold L, Sharon E, Thomas A. Patterns of care and survival among patients with malignant mesothelioma in the United States. Lung Cancer. 2017 Oct;112:102–8.
Gong W, Ye X, Shi K, Zhao Q. Primary malignant pericardial mesothelioma-a rare cause of superior vena cava thrombosis and constrictive pericarditis. J Thorac Dis. 2014 Dec;6(12):E272-275.
Grosu HB, Molina S, Casal R, Song J, Li L, Diaz‐Mendoza J, et al. Risk factors for pleural effusion recurrence in patients with malignancy. Respirology. 2019 Jan;24(1):76–82.
Jänne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, et al. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer. 2005 Jul;7(1):40–6.
Johns Hopkins Medicine. Radical Orchiectomy.
Klotz LV, Lindner M, Eichhorn ME, Grützner U, Koch I, Winter H, et al. Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma. J Thorac Dis. 2019 May;11(5):1963–72.
Mayo Clinic. Pericardial effusion.
Medscape. Pleurectomy.
Mesothelioma Applied Research Foundation. News from the Science Session | 2022 International Symposium on Malignant Mesothelioma.
Mezei G, Chang ET, Mowat FS, Moolgavkar SH. Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis. Ann Epidemiol. 2017 May;27(5):348-359.e11.
Milman S, Ng T. Surgery for mesothelioma: Less is more, more or less. J Thorac Cardiovasc Surg. 2018 Apr;155(4):1867–8.
Moffitt Cancer Center. Pleurectomy/Decortication for Mesothelioma.
Murphy DJ, Gill RR. Overview of treatment related complications in malignant pleural mesothelioma. Ann Transl Med. 2017 Jun;5(11):235.
Nakamura A, Takuwa T, Hashimoto M, Kuroda A, Nakamichi T, Matsumoto S, et al. Clinical outcomes with recurrence after pleurectomy/decortication for malignant pleural mesothelioma. Ann Thorac Surg. 2020 May;109(5):1537–43.
National Cancer Institute. Surgery to Treat Cancer.
National Comprehensive Cancer Network. NCCN Guidelines Malignant Peritoneal Mesothelioma.
Nazemi A, Nassiri N, Pearce S, Daneshmand S. Testicular mesothelioma: an analysis of epidemiology, patient outcomes, and prognostic factors. Urology. 2019 Apr;126:140–4.
Neugut AI, Prigerson HG. Curative, life-extending, and palliative chemotherapy: new outcomes need new names. Oncologist. 2017 Aug 1;22(8):883–5.
Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, et al. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2022 Feb;33(2):129–42.
Sugarbaker PH, Chang D. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. Eur J Surg Oncol. 2017 Jul;43(7):1228–35.
Vlahu T, Vigneswaran WT. Pleurectomy and decortication. Ann Transl Med. 2017 Jun;5(11):246.
Wolf AS, Flores RM. Special issue: mesothelioma. Ann Transl Med. 2017 Jun;5(11):229.
Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, et al. A novel tumor‐node‐metastasis (Tnm) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database*. Cancer. 2011 May;117(9):1855–63.
Free Mesothelioma Treatment Guide
Katy Moncivais, Ph.D., has more than 15 years of experience as a medical communicator. As the Medical Editor at Mesothelioma.com, she ensures our pages and posts present accurate, helpful information.
Dr. Francis Perry Wilson is the Director of the Clinical and Translational Research Accelerator at the Yale University School of Medicine. He specializes in nephrology and clinical research.